How I Treat in Brief: Venous Thromboembolism in Sickle Cell Disease
Arun S. Shet, MD, from the NIH’s National Heart, Lung, and Blood Institute, and Ted Wun, MD, from UC Davis Comprehensive Cancer Center in...
Learning From Leaders: An Interview With Leonard Zon, MD
Leonard Zon, MD, one of two 2019 ASH Mentor Award recipients, talks about the importance of hiring nice people who also happen to be...
You Make the Call: Could hormonal contraceptives contribute to a renal infarction in a...
This month, Joel Bennett, MD, discusses anticoagulation options for a young patient with a renal infarction and patent foramen ovale.
And don't forget to check...
You Make the Call: How would you treat a fit 72-year-old with very active...
This month, Joseph Mikhael, MD, MEd, discusses approaches for a fit 72-year-old patient with very active myeloma.
And don't forget to check out next month's clinical...
Lift as You Climb: An Interview With Michael R. DeBaun, MD, MPH
Michael R. DeBaun, MD, MPH, one of two 2019 ASH Mentor Award recipients, speaks about his family code of serving others, which he passes...
How To Give a Talk
In this special edition of “How We Teach,” Mikkael Sekeres, MD, MS, and Joseph Mikhael, MD, MEd, offer advice to new – and experienced –...
You Make the Call: Is upfront transplant appropriate for this patient with a rare...
This month, Mitchell Smith, MD, PhD, discusses the role of transplant in gamma-delta T-cell lymphoma.
And don't forget to check out next month's clinical dilemma...
How I Treat In Brief: Primary Mediastinal B-Cell Lymphoma
Recently, Lisa Giulino-Roth, MD, from Weill Cornell Medical College in New York, discussed the management of primary mediastinal B-cell lymphoma, a rare subtype of...
How would you treat a patient with a prolonged PTT and antiphospholipid antibodies?
This month, Caroline Berube, MD, discusses treatment for a patient with a prolonged PTT and antiphospholipid antibodies.
And don't forget to check out next month's...
From ASH Meeting on Hematologic Malignancies: How would you treat relapsed/refractory myeloma after transplant?
During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...
Current Issue
December 2019, Volume 5, Issue 15
This issue examines the hidden costs of participating in clinical trials, explores the pediatric hematology/oncology workforce, and more.
